From December 1, 2022 to February 28, 2023, the company has repurchased 30,000 shares, representing 0.03% for CAD 0.03 million. With this, the company has completed the repurchase of 30,000 shares, representing 0.03% for CAD 0.03 million under the buyback announced on November 30, 2022.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.79 CAD | -1.25% | -1.25% | -4.82% |
1st Jan change | Capi. | |
---|---|---|
-4.82% | 52.67M | |
-.--% | 339M | |
+26.34% | 277M | |
+11.34% | 253M | |
+42.73% | 194M | |
+146.60% | 144M | |
+34.78% | 132M | |
-43.53% | 123M | |
-28.57% | 121M | |
-7.69% | 93.71M |
- Stock Market
- Equities
- LOVE Stock
- News Cannara Biotech Inc.
- Tranche Update on Cannara Biotech Inc.'s Equity Buyback Plan announced on November 30, 2022.